Background: Low-grade cribriform cystadenocarcinomas (LGCCC) are rare salivary gland tumors, classified into a variant of cystadenocarcinoma by the 2005 WHO classification. All previously reported cases arose from parotid glands, except for a case from a minor salivary gland. We report here for the first time a case of LGCCC arising from the submandibular gland. Case: A 65-year-old man presented with a 4-cm multicystic mass in the left submandibular gland. Smears from fine-needle aspiration cytology showed tumor cells, appearing solitarily or partly in clusters, with thick cytoplasm and central nuclei. Some clustering tumor cells showed large cytoplasmic vacuoles and peripherally dislocated nuclei. Although these findings indicated a possible mucoepidermoid carcinoma in the submandibular gland, the final diagnosis of the resected specimen was LGCCC. Conclusion: LGCCC can arise not only from the parotid glands, but also in the submandibular glands. LGCCC is thought to be of low-grade malignancy; no reported cases have shown tumor metastasis and there are no patients who are known to have died of this disease. Thus, differential diagnosis of this tumor from other malignant salivary gland tumors is quite important; however, this might be difficult when based solely on cytological findings.

1.
Brandwein-Gensler MS, Skálová A, Nagao T: Salivary duct carcinoma; in Barnes L, Eveson JW, Reichart P, Sidransky D (eds): World Health Organization Classification of Tumors. Pathology & Genetics. Head and Neck Tumors. Lyon, IARC Press, 2005, pp 236–237.
2.
Delgado R, Klimstra D, Albores-Saavedra J: Low-grade salivary duct carcinoma. A distinctive variant with a low grade histology and predominant intraductal. Cancer 1996;78:958–967.
3.
Brandwein-Gensler MS, Hille J, Wang BY, Urken M, Gordon R, Wang LJ, Simpson JRM, Simpson RHW, Gnepp DR: Low-grade salivary duct carcinoma, description of 16 cases. Am J Surg Pathol 2004;28:1040–1044.
4.
Brandwein-Gensler MS, Gnepp DR: Low-grade cribriform cystadenocarcinoma; in Barnes L, Eveson JW, Reichart P, Sidransky D (eds): World Health Organization Classification of Tumors. Pathology & Genetics. Head and Neck Tumors. Lyon, IARC Press, 2005, p 233.
5.
Weinreb I, Tabanda-Lichauco R, Van der Kwast T, Perez- Ordonez B: Low-grade intraductal carcinoma of salivary gland: report of 3 cases with marked apocrine differentiation. Am J Surg Pathol 2006;30:1014–1021.
6.
Simpson RHW, Desai S, Palma SD: Salivary duct carcinoma in situ of the parotid gland. Histopathology 2008;53:416–425.
7.
Arai A, Taki M, Mimaki S, Ueda M, Hori S: Low-grade cribriform cystadenocarcinoma of the parotid gland: a case report. Auris Nasus Larynx 2009;36:725–728.
8.
Nakatsuka S, Harada H, Fujiyama H, Takeda K, Kimura H, Nagano T, Ito M, Asada Y: An invasive adenocarcinoma of the accessory parotid gland: a rare example developing from a low-grade cribriform cystadenocarcinoma? Diagn Pathol 2011;6:122.
9.
Weinreb I: Intraductal carcinoma of salivary gland (so-called low-grade cribriform cyst adenocarcinoma) arising in an intraparotid lymph node. Head Neck Pathol 2011;5:321–325.
10.
Nakazawa T, Kondo T, Yuminomochi T, Nakazawa K, Ishii Y, Mochizuki K, Kawasaki T, Yamane T, Miyata M, Motosugi U, Katoh R: Fine-needle aspiration biopsy of low-grade cribriform cystadenocarcinoma of the salivary gland. Diagn Cytopathol 2011;39:218–222.
11.
Laco J, Podhola M, Dolezalova H: Low-grade cribriform of the parotid gland: a neoplasm with favorable prognosis, distinct from salivary duct carcinoma. Int J Surg Pathol 2010:18;369–373.
12.
Simpson RHW, Prasas AR, Lewis JE, Skálová A, David L: Mucin-rich variant of salivary duct carcinoma: a clinicopathologic and immunohistochemical study of four cases. Am J Surg Pathol 2003;27:1070–1079.
13.
Ellis G, Simpson RHW: Acinic cell carcinoma; in Barnes L, Eveson JW, Reichart P, Sidransky D (eds): World Health Organization Classification of Tumors. Pathology & Genetics. Head and Neck Tumors. Lyon, IARC Press, 2005, pp 216–218.
14.
Skálová A, Vanecek T, Sima R, Laco J, Weinreb I, Perez-Ordonez B, Starek I, Geierova M, Simpson RH, Passador-Santos F, Ryska A, Leivo I, Kinkor Z, Michal M: Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto underdescribed salivary gland tumor entity. Am J Surg Pathol 2010;34:599–608.
15.
Kumasa S, Yuba R, Saqara S, Okutomi T, Okada Y, Mori M: Mucoepidermoid carcinomas: immunohistochemical studies on keratin, S-100 protein, lactoferrin, lysozyme and amylase. Basic Appl Histochem 1988;32:429–441.
16.
Brandwein-Gensler MS, Skálová A, Nagao T: Mucoepidermoid carcinoma; in Barnes L, Eveson JW, Reichart P, Sidransky D (eds): World Health Organization Classification of Tumors. Pathology & Genetics. Head and Neck Tumors. Lyon, IARC Press, 2005, pp 219–220.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.